1. Home
  2. ENTA vs CVGW Comparison

ENTA vs CVGW Comparison

Compare ENTA & CVGW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

HOLD

Current Price

$12.85

Market Cap

486.3M

Sector

Health Care

ML Signal

HOLD

Logo Calavo Growers Inc.

CVGW

Calavo Growers Inc.

HOLD

Current Price

$26.22

Market Cap

463.3M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENTA
CVGW
Founded
1995
1924
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Specialty Foods
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
486.3M
463.3M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
ENTA
CVGW
Price
$12.85
$26.22
Analyst Decision
Strong Buy
Buy
Analyst Count
5
2
Target Price
$20.40
$33.50
AVG Volume (30 Days)
283.1K
594.7K
Earning Date
02-09-2026
01-14-2026
Dividend Yield
N/A
3.08%
EPS Growth
N/A
N/A
EPS
N/A
1.11
Revenue
$65,324,000.00
$648,434,000.00
Revenue This Year
$0.99
$13.89
Revenue Next Year
$0.19
$11.67
P/E Ratio
N/A
$23.44
Revenue Growth
N/A
N/A
52 Week Low
$4.09
$18.40
52 Week High
$17.15
$28.72

Technical Indicators

Market Signals
Indicator
ENTA
CVGW
Relative Strength Index (RSI) 41.35 80.84
Support Level $12.09 $21.85
Resistance Level $13.98 $22.46
Average True Range (ATR) 0.73 0.79
MACD -0.22 0.47
Stochastic Oscillator 19.01 76.43

Price Performance

Historical Comparison
ENTA
CVGW

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

About CVGW Calavo Growers Inc.

Calavo Growers Inc is engaged in the sourcing, packing, and distribution of fresh avocados, tomatoes, and papayas, and the processing of guacamole and other avocado products. The company delivers products to retail grocers, club and mass-merchandise stores, foodservice operators, and wholesalers, sourcing avocados from California, Mexico, and other key growing regions. Its operations include sorting, packing, ripening, and shipping fresh produce, and processing and packaging fresh and frozen guacamole. The company operates through two segments: Fresh, including avocados, tomatoes, papayas, and other fresh produce products, and Prepared, including guacamole and avocado pulp, with the majority of revenue generated from the Fresh segment and geographically from the United States.

Share on Social Networks: